Stockscreener 앱 받기
1.12
2.75%
0.03
시간 외 거래:
1.16
0.04
+3.57%
Mustang Bio Inc 주식(MBIO)의 최신 뉴스
Geode Capital Management LLC Purchases 38,951 Shares of Mustang Bio, Inc. (NASDAQ:MBIO) - Defense World
Closing Bell Recap: Mustang Bio Inc (MBIO) Ends at 1.22, Reflecting a -1.61 Downturn - DWinneX
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - MSN
Mustang Bio stock plunges to 52-week low of $1.12 - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.12 By Investing.com - Investing.com South Africa
Financial Analysis: Bio-Key International Inc (BKYI)’s Ratios Unveil Key Insights - DWinneX
Mustang Bio (MBIO) Sells Facility to AbbVie for $1 Million - GuruFocus
Mustang Bio Inc: Rising -98.18% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com
Mustang Bio (MBIO) Regains Nasdaq Compliance - GuruFocus
Now Is The Time To Build A Position In Mustang Bio Inc (NASDAQ:MBIO) - Marketing Sentinel
What to expect from MBIO’s earnings report this quarter? - uspostnews.com
Mustang Bio stock hits 52-week low at $1.20 amid sharp decline - Investing.com Canada
Mustang Bio stock hits 52-week low at $1.20 amid sharp decline By Investing.com - Investing.com South Africa
Mustang Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Mustang Bio Inc. (MBIO) reports earnings - Quartz
MUSTANG BIO, INC. SEC 10-K Report - TradingView
Mustang Bio stock plunges to 52-week low of $1.35 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.35 - Investing.com India
Fortress Biotech partners with Partex for AI-driven drug discovery - Investing.com
Car T Cell Therapy Market Demand, Statistics, Future Growth and Outlook 2025-2032 | Mustang Bio, Fate Therapeutics - openPR
Mustang Bio stock plunges to 52-week low of $1.43 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.43 - Investing.com India
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Petri Dish: Biotech leaves Worcester; Novo Nordisk, Eli Lilly partnerships - The Business Journals
Mustang Bio Regains Nasdaq Compliance, Secures Position For Cell Therapy Advancements - Nasdaq
Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com Canada
Mustang Bio meets Nasdaq’s equity listing requirements - Investing.com India
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times
Mustang Bio, Inc. Regains Compliance with Nasdaq Capital Market Listing Requirements - Nasdaq
Mustang Bio Overcomes Delisting Threat: What This Nasdaq Compliance Means for Investors - StockTitan
BRIEF—Mustang Bio sells assets; focuses on MB-109, MB-108 and MB-101 - The Pharma Letter
Mustang Bio (MBIO) Projected to Post Earnings on Monday - Defense World
Mustang Bio stock plunges 29% on lease termination news - MSN
Mustang Bio stock plunges to 52-week low at $2 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low at $2 - Investing.com
Mustang Bio exits Worcester facility, sells assets to AbbVie By Investing.com - Investing.com India
Mustang Bio stock plunges 29% on lease termination news (MBIO:NASDAQ) - Seeking Alpha
Mustang Bio exits lease for Massachusetts facility, divests equipment - TipRanks
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility -February 27, 2025 at 05:49 pm EST - Marketscreener.com
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility - MarketWatch
Mustang Bio exits Worcester facility, sells assets to AbbVie - Investing.com
0.39%
3.66%
자본화:
|
볼륨(24시간):